Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Divakaran

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Cardiology|July 20, 2025
Diagnoses and outcomes of patients referred for FDG PET/CT for suspected cardiac sarcoidosisStephen J Hankinson, Sylvain L Carre, Shelby S Laychak, et al.
Circulation. Cardiovascular Imaging|October 9, 2025
Utility of <sup>18</sup>F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery DiseaseDiana M Lopez, Daniel M Huck, Sanjay Divakaran, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathiesShiva Tabaghi, Graham H Bevan, Stephen Hankinson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 14, 2026
Ventricular Tachycardia Ablation Associated Abnormalities on FDG PET/CT in Patients with Suspected Cardiac SarcoidosisBrigitte Kazzi, Stephen J Hankinson, Sylvain L Carre, et al.
JACC. Cardiovascular Imaging|March 21, 2021
Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory DisordersBrittany N Weber, Emma Stevens, Lourdes M Perez-Chada, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 20, 2019
Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteriaSanjay Divakaran, Avinainder Singh, Ersilia M DeFilippis, et al.
European Journal of Preventive Cardiology|June 17, 2020
Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI RegistryAdam N Berman, David W Biery, Avinainder Singh, et al.
JAMA Network Open|July 9, 2020
Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI RegistryDavid W Biery, Adam N Berman, Avinainder Singh, et al.
Journal of the American Heart Association|May 18, 2024
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Cardiovascular Diabetology|July 18, 2024
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Cardiology|July 20, 2025
Diagnoses and outcomes of patients referred for FDG PET/CT for suspected cardiac sarcoidosisStephen J Hankinson, Sylvain L Carre, Shelby S Laychak, et al.
Circulation. Cardiovascular Imaging|October 9, 2025
Utility of <sup>18</sup>F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery DiseaseDiana M Lopez, Daniel M Huck, Sanjay Divakaran, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathiesShiva Tabaghi, Graham H Bevan, Stephen Hankinson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 14, 2026
Ventricular Tachycardia Ablation Associated Abnormalities on FDG PET/CT in Patients with Suspected Cardiac SarcoidosisBrigitte Kazzi, Stephen J Hankinson, Sylvain L Carre, et al.
JACC. Cardiovascular Imaging|March 21, 2021
Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory DisordersBrittany N Weber, Emma Stevens, Lourdes M Perez-Chada, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 20, 2019
Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteriaSanjay Divakaran, Avinainder Singh, Ersilia M DeFilippis, et al.
European Journal of Preventive Cardiology|June 17, 2020
Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI RegistryAdam N Berman, David W Biery, Avinainder Singh, et al.
JAMA Network Open|July 9, 2020
Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI RegistryDavid W Biery, Adam N Berman, Avinainder Singh, et al.
Journal of the American Heart Association|May 18, 2024
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Cardiovascular Diabetology|July 18, 2024
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Pageof 12